The efficacy of two intragenic polymorphic markers of factor Vlll gene has been examined in Andhra Pradesh population with a view to confirm/revise the strategy for carrier detection that would be precise and economical. The haemophilia A carrier was detected using Bcl I and Xba 1 polymorphic sites in intron 18 and 22 respectively. The cumulative efficiency of these two sites for detection of carriers is 100% since all 15 families tested were informative for one of these polymorphisms, thus confirming their usefulness for factor VIII gene mutations found in Andhra Pradesh.
INTRODUCTION
Due to high heterogeneity of mutations causing haemophilia A and considering the size and structural complexity of factor VIII gene, direct diagnosis of molecular defect causing haemophilia A is difficult. Most of the disease causing mutations are sporadic and new mutations are bound to occur. However, polymorphisms have been used to track mutant gene and hence follow it in a pedigree. To be of diagnostic use, a polymorphism must differentiate the two X-chromosomes of a female carrier. In haemophilia gene, the most useful polymorphisms are bi-allelic. They are formed by a single nucleotide substitution that either creates or deletes a restriction enzyme cleavage site in the gene. If there is a variation in normal polymorphic site, the cutting site of restriction enzyme is altered, and hence these fragments will vary in length not only from one individual to another, but also between the two X-chromosomes of a female.This can be used to identify the gene(allele) that carries the mutation(I). There are two other useful multiallelic polymorphisms in the CA repeats of FVlII gene. One is in intron 13 and the other in intron 22. In addition, there are two extragenic polymorphisms adjacent to FVIII gene that carry a risk of recombination (hence at risk of misdiagnosis up to 5%). The heterozygosity of a woman for any polymorphism decides its usefulness in tracking X-chromosomes carrying an affected gene. Population based variations have given a lot of scope for further study in other ethnic groups in order to assess their usefulness.
Bcl I and Xba I markers have been found to be useful in migrant Indians and many other populations (2). Shetty et al (3) have reported of the usefulness of these markers in some of the families from the sub continent. In a more recent study Roy et al (4) reported two new markers Hind III and intron 22 dinucleotide repeats in Indian population.
In India with its large population, the estimated number of haemophilia A patients is over 50,000. This alone prompts one to compile data on the nature of mutations occuring in our population and also documenting useful polymorphic sites associated with this gene. We have attempted PCR based analysis of two polymorphic sites on factor VIII gene in haemophilia A families in Andhra Pradesh.
VIII levels ranged from >1 to 12 units/dl. DNA was extracted from whole blood of normal subjects and patients of haemophilia A and their relatives using standard protocol (5).
PCR conditions for Bcl I polymorphism analysis:
250 ng of genomic DNA was added toa PCR mix containing 200 ~LM dNTP's, 10 x PCR Taq buffer (10mM Tris (pH 8.3), 50raM KCI, 15 mM MgCI 2 and 0.01% Gelatin), 25raM MgCI 2, 1.5 units of Taq polymerase and 10 pmol each of oligonucleotide primers (8.1 and 8.2, Table 1 ). The solution was made upto 25 ILl with distilled water. Initial denaturation temperature was setup at 95~ for 5 minutes after which 29 cycles of PCR was performed each cycle consisting denaturation for one minute at 90~ annealing for 1 minute at 62~ and extension step at 72~ for 1 minute, final elongation step was for 10 minutes. After confirming amplification, the remaining PCR product was subjected to 3 units of Bcl I restriction enzyme digestion at 55~ over night. The digested product was then electrophoresed on polyacrylamide gel as described by Kogan et al (6) . The amplified fragment size from mutant chromosome was 142 bp (due to abolition of this site).
PCR conditions for Xba I polymorphism analysis:
250 ng of genomic DNA was added to an aliquot containing 10 x PCR Taq buffer (10mM Tris (pH 8.3), 50mM KCI, 15 mM MgCI 2 and 0.01% Gelatin) 200 I.LM dNTP's, 1.5 units of Taq polymerase and 10 pmol each of oligonucleotide primers (7.1 and 7.10, Table-1).After an initial denaturation of 95~ for 5 minutes, PCR amplification was carried out for 34 cycles each consisting of the following: denaturation for 30 seconds at 95~ annealing at 62DC for 30 seconds and extension step at 72~ for 30 seconds. This was followed by an extension step at 67~ for 5 minutes.Amplified product is 96 bp. Restriction enzyme digestion was carried out by the addition of 3 units of Xba I restriction enzyme and incubating at 37~ over night.Digested samples were run on 12% polyacrylamide gel at 70V for one hour followed by ethidium bromide staining. Normal samples give 96bp band and carriers give 96,68 and 28 bp bands. Figure 1 shows analysis and carrier Figure 2 illustrates the informativeness of Xba I polymorphism. DNA samples from this family were amplified using primers 7.1 and 7.10 ( Table 1 ).The amplified 96 bp fragment corresponds to regions of the factor VIII gene as well as a homologous region in the human genome elsewhere (7) . When digested with Xba I the association of the disease with Xba I in this familiy is confirmed by the presence of 68 bp and 28 bp products. Table 2 represents the details of family studies, range of FVIII levels and informativeness for the polymorphic markers used. Out of 15 families studied 13 families are severe to moderately severe (< 2 to 2 -10 units/dl) and 2 families are mild (>10 -30 units/dl of F VIII).
RESULTS AND DISCUSSION
10 families out of 15 tested were informative for Bcl I polymorphism (intron 18) which is almost 67% whereas in 33% of families Xba I for intron 22 was informative. In all the 15 haemophilia A families studied either one of these two polymorphic markers were informative i.e., heterozygous in the female. Surprisingly in the 10 families which are informative for Bcl I polymorphic site, most of them are severe to moderately severe cases.
Though there is a marked variation in the polymorphisms associated with this disease among different ethnic groups, Bcl I and Xba I are found to be two usefut ones for haemophilia A diagnosis (2, (8) (9) (10) (11) . This study was conducted to confirm the usefulness of these two intragenic markers in A.P population. In all the 15 families both the polymorphisms were tested.We were able to give carrier status in the female siblings. However, Bcl I is the predominant marker where the heterozygosity rate in the females was 67%. Xba I proved to be a good combination as it was informative in the rest of the families thereby giving a 100% carrier detection rate. Thi's study underlines the importance of screening for Bcl I and Xba I polymorphic sites in the Indian subcontinent for routine diagnosis and genetic counseling. Although we have not tested as many polymorphisms reported by others (4) and also the number of the families tested are small, the importance of testing the above two polymorphisms can not be minimized. 
